Volume 26, Number 47
December 9, 2001
A Dose of Reality
For the inventor of aspirin, it must’ve been a bitter pill to
swallow.
German chemist Felix Hoffman stumbled upon the miracle drug in the
late 1890s while trying to treat his father’s painful rheumatism. As
early as 200 B.C., healers had known that chewing on the bark of the white
willow soothed aches and pains, but it was Hoffman who improved on the work of
others and finally came up with a way to make pure, stable acetylsalicylic acid.
Hoffman reported his findings to his supervisor at the Friedrich
Bayer Company, a man named Heinrich Dreser who, ironically, invented heroin,
which he thought was a non-addictive substitute for morphine. So in 1900,
aspirin pills hit the market. Dreser retired early, and rich, and the
Bayer family became fabulously wealthy. As for Hoffman, he was entitled to
royalties on any patented invention, but aspirin was never successfully patented
in Germany because of World War One. In 1918, the American government
seized Bayer’s U.S. assets under the Trading With the Enemy Act and auctioned
them off to the Sterling Products Company of West Virginia. Hoffman never made
much money.
Adding insult to injury, aspirin became the world’s most widely
used medicine just ten years after its invention, because it worked and had no
side effects. In 1950, it was the best-selling painkiller of all time. In
1970, researchers found an aspirin enzyme that helps stop the formation of blood
clots that cause strokes and heart attacks. Soon after, Swedish
researchers discovered that aspirin also blocks the making of chemicals that
cause headaches, fevers and problems with the immune system.
Today, Americans swallow 80 million aspirins a day -- the same
amount as the rest of the world combined. Most are taken to prevent heart
disease. But since roughly six percent of people can’t handle straight
aspirin, some kinds are “buffered” with a slow-disolving coating that
prevents the drug from being absorbed by the body until it leaves the stomach
and goes into the intestines.
So if Jesus is the Great Physician, love is the aspirin He
dispenses. Many before him had tried to administer love, but only He could
perfect it, making it pure and stable enough to reproduce endlessly. Love
enriches all of us, even those who develop all kinds of competing, poisonous
potions to kill the pain of this broken world. It often seems the only one
who doesn’t benefit is the One who brought us love in the first place, only to
see it used for greed and personal gain. We use his own gift against him.
All around us, love is commandeered by our culture. The
enemies of the cross take it out of the hands of the church and auction it off
to anyone willing to pay the high price they exact. Love is powerful, even
in the hands of those who know nothing of it but, in its new packaging, the
Originator goes unrecognized.
Love’s effectiveness does not. It works. It has no
side effects, except for the symptoms of the Spirit’s inner presence. It
eases pain and soothes the fevered soul. Love also keeps the blood of
Jesus flowing freely through the Body, preventing the deadly obstructions that
keep it from carrying grace and freedom to every corner.
Love even prevents heart disease -- that wasting, withering plague
that either kills the Body quickly or slowly saps it of its vigor. In ways
we’re just beginning to understand, love in the church prevents not only
headaches, but heartaches that would otherwise destroy.
Though love is a daily requirement, sometimes it’s too strong for
the Body to absorb all at once so the Lord
buffers the effects, recognizing it takes time for us to adjust to his reality.
He still moves in mysterious ways, using love, not to mask the pain, but to
remove it.
It’s a powerful, powerful thing, especially vital for those who
are hurting the most. But one word of caution. If you’re in a
place in your life where you’re still not accepting the love of Jesus, there
is no substitute. Don’t take anything for it.
By Rick Gamble, published in Cross Current, Brantford, Ontario, Canada.
Reprint at will in not-for-profit publications.